Systematic Review of Sodium-glucose Cotransporter 2 Inhibitors in the Treatment of Non-diabetic Diseases
Sodium-glucose cotransporter 2(SGLT-2)inhibitor,as a new type of hypoglycemic agent,brings new benefits to diabetic patients.Recent studies have found that SGLT-2 inhibitors have significant therapeutic effects on non-diabetic diseases such as cardiovascular disease,kidney disease,weight loss,and non-alcoholic fatty liver disease.Here is to make a review on the mechanism,safety and clinical application of SGLT-2 inhibitors in non-diabetic diseases,so as to provide more clinical application basis for SGLT-2 inhibitors in the treatment of non-diabetic diseases.